Imugene Market Cap

Imugene has a market cap or net worth of 194.14 million as of April 23, 2025. Its market cap has decreased by -72.08% in one year.

Market Cap

194.14M

Enterprise Value

176.16M

Revenue

-1.84M

Ranking

n/a

PE Ratio

n/a

Stock Price

0.03

Market Cap Chart

Since September 17, 2002, Imugene's market cap has increased from 7.38M to 194.14M, an increase of 2,531.10%. That is a compound annual growth rate of 15.56%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	194.14M	-29.45%
Dec 31, 2024	275.18M	-65.11%
Dec 29, 2023	788.60M	-15.31%
Dec 30, 2022	931.15M	-59.62%
Dec 31, 2021	2.31B	386.45%
Dec 31, 2020	474.09M	234.74%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro
Dec 31, 2015	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
CSL Limited	115.90B
Pro Medicus	21.64B
Cochlear	17.02B
Sonic Healthcare	12.19B
Telix Pharmaceuticals	8.51B
Ramsay Health Care	7.67B
Ansell	4.26B
Mesoblast	2.11B

Market Cap Rankings